Company WuXi Biologics (Cayman) Inc. OTC Markets
Equities
WXXWY
US98260N1081
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.83 USD | +0.61% |
|
+1.07% | -62.01% |
Jun. 01 | US lawmakers ask FBI for briefing on GenScript Biotech's links to China | RE |
May. 31 | US lawmakers ask FBI for briefing on GenScript Biotech's links to China | RE |
Business Summary
Number of employees: 12,740
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biologics
88.8
%
| 2,582 | 14.5 % | 16,717 | 88.8 % | +547.32% |
XDC
11.2
%
| - | - | 2,106 | 11.2 % | - |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
47.4
%
| 9,880 | 55.6 % | 8,921 | 47.4 % | -9.71% |
Europe
30.2
%
| 2,961 | 16.7 % | 5,681 | 30.2 % | +91.85% |
China
18.3
%
| 4,325 | 24.4 % | 3,449 | 18.3 % | -20.24% |
Rest of the World
4.1
%
| 590 | 3.3 % | 772 | 4.1 % | +30.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 11-05-31 |
Ming Tu
DFI | Director of Finance/CFO | 54 | 21-08-22 |
Gu Jijie
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Weichang Zhou
BRD | Director/Board Member | 59 | 12-11-30 |
Yue Huang
SEC | Corporate Secretary | - | 18-11-19 |
Ying Man Sham
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jackson Tai
BRD | Director/Board Member | 73 | 23-05-05 |
William Keller
BRD | Director/Board Member | 75 | 17-05-16 |
Ge Li
CHM | Chairman | 56 | 10-04-30 |
Yan Ling Cao
BRD | Director/Board Member | 39 | 16-04-30 |
Yi Bing Wu
BRD | Director/Board Member | 55 | 16-04-30 |
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 11-05-31 |
Weichang Zhou
BRD | Director/Board Member | 59 | 12-11-30 |
Kenneth Hitchner
BRD | Director/Board Member | 63 | 20-06-08 |
Jue Chen
BRD | Director/Board Member | 54 | 23-08-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,280,124,252 | 3,658,514,735 ( 85.48 %) | 17,642,323 ( 0.4122 %) | 85.48 % |
Company contact information
![address WuXi Biologics (Cayman) Inc.(WXXWY)](https://cdn.zonebourse.com/static/address/120796697.png)
Group companies
Name | Category and Sector |
---|---|
WuXi Biologics (Hong Kong) Ltd.
|
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.03% | 125B | |
+13.22% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-12.73% | 16.37B | |
+0.90% | 13.58B | |
+26.48% | 11.66B |
- Stock Market
- Equities
- 2269 Stock
- WXXWY Stock
- Company WuXi Biologics (Cayman) Inc.